Vilazodone (Viibryd) is a serotonergic antidepressant developed by Clinical Datafor the treatment of major depressive disorder. The chemical compound was originally developed by Merck KGaA(Germany). Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder in 2011. Its activity can be thought of as a combination of an SSRI and buspirone in some ways.
- ProName: Vilazodone
- CasNo: 163521-12-8
- Molecular Formula: C26H27N5O2
- Appearance: light yellow solid
- Application: Usage Labelled analogue of Vilazodone …
- PackAge: Cardboard
- ProductionCapacity: Metric Ton/Day
- Purity: 98%
- Storage: Refrigerator
- LimitNum: 0 Metric Ton
- Moisture Content: ＜0.5%
- Impurity: ＜0.5%
No comments:
Post a Comment